Glytec

Glytec is a healthcare company in Atlanta, United States, founded in 2006. It has raised $57.0M across 2 rounds, most recently a $36.0M Growth Equity in June 2025.

The Industry Leader in Intelligent Glycemic Management

Headquarters
Atlanta, Georgia
Employees
51–200
Founded
2006
Business Model
B2B
Website
glytec.com
Total Funding
$57.0M
Last Round
$36.0M Growth EquityJun 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Glytec provides hospitals and health systems with GlytecOne, an insulin management platform supporting consistent glycemic care across patients, acuity levels, and clinical roles. Glucommander supplies validated guidance for clinicians, while Command Center gives leaders visibility into risk and performance across the enterprise.

Summary

It lists 51–200 employees. It has raised $57.0M in total across 2 rounds, most recently a $36.0M Growth Equity round in Jun 2025. Investors include Hayfin Capital Management and Silicon Valley Bank.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth InvestmentJun 2025
$36.0M

Sign up to see all 2 events

Funding: Venture Round through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Glytec on Indexed.vc
<a href="https://indexed.vc/companies/glytec"><img src="https://indexed.vc/api/badge/company/glytec" alt="Glytec on Indexed.vc" width="260" height="76" /></a>